Ivan S. Pires
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Cell Biology top 10%
- Hemoglobin structure and function
Papers in
- Cell Biology 16
- Hemoglobin structure and function 16
-
- Heme Oxygenase-1 and Carbon Monoxide 6
- Co-authors
- Darrell J. Irvine (11 shared papers)Andre F. Palmer (19 shared papers)Paula T. Hammond (9 shared papers)Donald A. Belcher (5 shared papers)Matteo Gentili (1 shared paper)Paul C. Blainey (1 shared paper)Nir Hacohen (1 shared paper)Rebecca J. Carlson (1 shared paper)
- Journals
- Biotechnology and Bioengineering (2 papers)Biomedicine & Pharmacotherapy (2 papers)Bioengineering & Translational Medicine (2 papers)Journal of Pharmaceutical Sciences (1 paper)Transfusion (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Ivan S. Pires
29 papers receiving 586 citations
Ivan S. Pires's Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology 239
- Cell Biology 132
- Oncology 142
- Infectious Diseases 63
- Molecular Biology 229
Countries citing papers authored by Ivan S. Pires
This map shows the geographic impact of Ivan S. Pires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan S. Pires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan S. Pires more than expected).
Fields of papers citing papers by Ivan S. Pires
This network shows the impact of papers produced by Ivan S. Pires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan S. Pires. The network helps show where Ivan S. Pires may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan S. Pires, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity Hit paper breakdown → | 2023 | 128 |
| 2 | Human STING is a proton channel Hit paper breakdown → | 2023 | 111 |
| 3 | 2021 | 77 | |
| 4 | 2019 | 31 | |
| 5 | 2022 | 25 | |
| 6 | 2020 | 21 | |
| 7 | 2019 | 18 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 17 | |
| 10 | 2017 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 2025 | 12 | |
| 13 | 2023 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2024 | 6 | |
| 20 | 2021 | 6 |
About Ivan S. Pires
Ivan S. Pires is a scholar working on Cell Biology, Molecular Biology, Physiology, Pediatrics, Perinatology and Child Health and Immunology, having authored 32 papers that have together received 591 indexed citations. Recurring topics across this work include Hemoglobin structure and function (16 papers), Erythrocyte Function and Pathophysiology (8 papers), Neonatal Health and Biochemistry (8 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers), Immunotherapy and Immune Responses (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (239 citations), Cell Biology (132 citations), Oncology (142 citations), Infectious Diseases (63 citations) and Molecular Biology (229 citations). Ivan S. Pires has collaborated with scholars based in United States and Germany. Frequent co-authors include Darrell J. Irvine, Andre F. Palmer, Paula T. Hammond, Donald A. Belcher, Matteo Gentili, Paul C. Blainey, Nir Hacohen, Rebecca J. Carlson, Marc A. Schwartz and Bingxu Liu. Their work appears in journals such as Biotechnology and Bioengineering, Biomedicine & Pharmacotherapy, Bioengineering & Translational Medicine, Journal of Pharmaceutical Sciences and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.